Five practical steps for pharma ahead of the XEVMPD deadline
This article was originally published in SRA
Executive Summary
Pharmaceutical organizations operating in the EU have until the end of 2014 to bring all their entries in the extended EudraVigilance Medicinal Product Dictionary into line with new updating requirements. Miranda Pothiawala plots out the steps companies must now take.